62 related articles for article (PubMed ID: 34905594)
1. Urolithin A protects dopaminergic neurons in experimental models of Parkinson's disease by promoting mitochondrial biogenesis through the SIRT1/PGC-1α signaling pathway.
Liu J; Jiang J; Qiu J; Wang L; Zhuo J; Wang B; Sun D; Yu S; Lou H
Food Funct; 2022 Jan; 13(1):375-385. PubMed ID: 34905594
[TBL] [Abstract][Full Text] [Related]
2. Teaghrelin protected dopaminergic neurons in MPTP-induced Parkinson's disease animal model by promoting PINK1/Parkin-mediated mitophagy and AMPK/SIRT1/PGC1-α-mediated mitochondrial biogenesis.
Jhuo CF; Chen CJ; Tzen JTC; Chen WY
Environ Toxicol; 2024 Jul; 39(7):4022-4034. PubMed ID: 38622810
[TBL] [Abstract][Full Text] [Related]
3. Transgenic expression and activation of PGC-1α protect dopaminergic neurons in the MPTP mouse model of Parkinson's disease.
Mudò G; Mäkelä J; Di Liberto V; Tselykh TV; Olivieri M; Piepponen P; Eriksson O; Mälkiä A; Bonomo A; Kairisalo M; Aguirre JA; Korhonen L; Belluardo N; Lindholm D
Cell Mol Life Sci; 2012 Apr; 69(7):1153-65. PubMed ID: 21984601
[TBL] [Abstract][Full Text] [Related]
4. Glia Maturation Factor Dependent Inhibition of Mitochondrial PGC-1α Triggers Oxidative Stress-Mediated Apoptosis in N27 Rat Dopaminergic Neuronal Cells.
Selvakumar GP; Iyer SS; Kempuraj D; Raju M; Thangavel R; Saeed D; Ahmed ME; Zahoor H; Raikwar SP; Zaheer S; Zaheer A
Mol Neurobiol; 2018 Sep; 55(9):7132-7152. PubMed ID: 29383690
[TBL] [Abstract][Full Text] [Related]
5. Menaquinone-4 alleviates hypoxic-ischemic brain damage in neonatal rats by reducing mitochondrial dysfunction via Sirt1-PGC-1α-TFAM signaling pathway.
Feng X; Zheng Y; Mao N; Shen M; Chu L; Fang Y; Pang M; Wang Z; Lin Z
Int Immunopharmacol; 2024 Jun; 134():112257. PubMed ID: 38759366
[TBL] [Abstract][Full Text] [Related]
6. Intranasal Delivery of Mitochondria Attenuates Brain Injury by AMPK and SIRT1/PGC-1α Pathways in a Murine Model of Photothrombotic Stroke.
Salman M; Stayton AS; Parveen K; Parveen A; Puchowicz MA; Parvez S; Bajwa A; Ishrat T
Mol Neurobiol; 2024 May; 61(5):2822-2838. PubMed ID: 37946007
[TBL] [Abstract][Full Text] [Related]
7. Fucoidan Improves D-Galactose-Induced Cognitive Dysfunction by Promoting Mitochondrial Biogenesis and Maintaining Gut Microbiome Homeostasis.
Xu Y; Xue M; Li J; Ma Y; Wang Y; Zhang H; Liang H
Nutrients; 2024 May; 16(10):. PubMed ID: 38794753
[TBL] [Abstract][Full Text] [Related]
8. Activation of the miR-34a-Mediated SIRT1/mTOR Signaling Pathway by Urolithin A Attenuates D-Galactose-Induced Brain Aging in Mice.
Chen P; Chen F; Lei J; Li Q; Zhou B
Neurotherapeutics; 2019 Oct; 16(4):1269-1282. PubMed ID: 31420820
[TBL] [Abstract][Full Text] [Related]
9. Methylated urolithin A, mitigates cognitive impairment by inhibiting NLRP3 inflammasome and ameliorating mitochondrial dysfunction in aging mice.
Chen P; Wang Y; Xie J; Lei J; Zhou B
Neuropharmacology; 2024 Jul; 252():109950. PubMed ID: 38636727
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of increased O-GlcNAc cycling against 6-OHDA induced Parkinson's disease pathology.
Kim DY; Kim SM; Cho EJ; Kwak HB; Han IO
Cell Death Dis; 2024 Apr; 15(4):287. PubMed ID: 38654003
[TBL] [Abstract][Full Text] [Related]
11. Protopanaxadiols Eliminate Behavioral Impairments and Mitochondrial Dysfunction in Parkinson's Disease Mice Model.
Zhao J; Wang J; Zhao K; Zhang Y; Hu W
Neurochem Res; 2024 Jul; 49(7):1751-1761. PubMed ID: 38551796
[TBL] [Abstract][Full Text] [Related]
12. Urolithin A's Role in Alleviating Severe Acute Pancreatitis via Endoplasmic Reticulum-Mitochondrial Calcium Channel Modulation.
Kang H; Hu Q; Yang Y; Huang G; Li J; Zhao X; Zhu L; Su H; Tang W; Wan M
ACS Nano; 2024 May; 18(21):13885-13898. PubMed ID: 38757565
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective mechanisms of red clover and soy isoflavones in Parkinson's disease models.
de Rus Jacquet A; Ambaw A; Tambe MA; Ma SY; Timmers M; Grace MH; Wu QL; Simon JE; McCabe GP; Lila MA; Shi R; Rochet JC
Food Funct; 2021 Nov; 12(23):11987-12007. PubMed ID: 34751296
[TBL] [Abstract][Full Text] [Related]
14. Metformin rescues Parkinson's disease phenotypes caused by hyperactive mitochondria.
Mor DE; Sohrabi S; Kaletsky R; Keyes W; Tartici A; Kalia V; Miller GW; Murphy CT
Proc Natl Acad Sci U S A; 2020 Oct; 117(42):26438-26447. PubMed ID: 33024014
[TBL] [Abstract][Full Text] [Related]
15. ATP Maintenance via Two Types of ATP Regulators Mitigates Pathological Phenotypes in Mouse Models of Parkinson's Disease.
Nakano M; Imamura H; Sasaoka N; Yamamoto M; Uemura N; Shudo T; Fuchigami T; Takahashi R; Kakizuka A
EBioMedicine; 2017 Aug; 22():225-241. PubMed ID: 28780078
[TBL] [Abstract][Full Text] [Related]
16. Urolithin A Hijacks ERK1/2-ULK1 Cascade to Improve CD8
Ma S; Wu Q; Wu W; Tian Y; Zhang J; Chen C; Sheng X; Zhao F; Ding L; Wang T; Zhao L; Xie Y; Wang Y; Yue X; Wu Z; Wei J; Zhang K; Liang X; Gao L; Wang H; Wang G; Li C; Ma C
Adv Sci (Weinh); 2024 May; 11(18):e2310065. PubMed ID: 38447147
[TBL] [Abstract][Full Text] [Related]
17. Urolithin A promotes mitophagy and suppresses NLRP3 inflammasome activation in lipopolysaccharide-induced BV2 microglial cells and MPTP-induced Parkinson's disease model.
Qiu J; Chen Y; Zhuo J; Zhang L; Liu J; Wang B; Sun D; Yu S; Lou H
Neuropharmacology; 2022 Apr; 207():108963. PubMed ID: 35065082
[TBL] [Abstract][Full Text] [Related]
18. Interactions of amyloidogenic proteins with mitochondrial protein import machinery in aging-related neurodegenerative diseases.
Reed AL; Mitchell W; Alexandrescu AT; Alder NN
Front Physiol; 2023; 14():1263420. PubMed ID: 38028797
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological Effects of Urolithin A and Its Role in Muscle Health and Performance: Current Knowledge and Prospects.
Zhao H; Song G; Zhu H; Qian H; Pan X; Song X; Xie Y; Liu C
Nutrients; 2023 Oct; 15(20):. PubMed ID: 37892516
[TBL] [Abstract][Full Text] [Related]
20. Urolithins: A Prospective Alternative against Brain Aging.
An L; Lu Q; Wang K; Wang Y
Nutrients; 2023 Sep; 15(18):. PubMed ID: 37764668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
